Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-01-22 @ 12:07 AM
Study NCT ID:
NCT05599334
Status:
COMPLETED
Last Update Posted:
2025-10-06
First Post:
2022-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
Sponsor:
Pierre Fabre Medicament
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-10
First Submit QC Date:
None
Study First Post Date:
2022-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-11
Results First Submit QC Date:
None
Results First Post Date:
2025-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-10-06
Last Update Post Date Type:
ESTIMATED